Back
Amplify Weight Loss Drug & Treatment ETF Stock Price Chart
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14
THNR
Amplify Weight Loss Drug & Treatment ETF
Last Price:
$22.09
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and THNR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Amplify Weight Loss Drug & Treatment ETF Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.54 | Buy |
| 20-day SMA: | 22.95 | Sell |
| 50-day SMA: | 22.88 | Sell |
| 200-day SMA: | 24.99 | Sell |
| 8-day EMA: | 22.6 | Sell |
| 20-day EMA: | 22.78 | Sell |
| 50-day EMA: | 23.02 | Sell |
| 200-day EMA: | 7.42 | Buy |
Amplify Weight Loss Drug & Treatment ETF Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 44.25 | Sell |
| Chaikin Money Flow: | 941 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.5 - 23.38) | Sell |
| Bollinger Bands (100): | (22.49 - 24.31) | Sell |
Amplify Weight Loss Drug & Treatment ETF Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amplify Weight Loss Drug & Treatment ETF Stock
Is Amplify Weight Loss Drug & Treatment ETF Stock a Buy?
-
Amplify Weight Loss Drug & Treatment ETF share price is 22.54 while THNR 8-day simple moving average is 22.54, which is a Buy signal.
-
The stock price of THNR is 22.54 while Amplify Weight Loss Drug & Treatment ETF 20-day SMA is 22.95, which makes it a Sell.
-
Amplify Weight Loss Drug & Treatment ETF 50-day simple moving average is 22.88 while THNR share price is 22.54, making it a Sell technically.
-
THNR stock price is 22.54 and Amplify Weight Loss Drug & Treatment ETF 200-day simple moving average is 24.99, creating a Sell signal.
THNR Technical Analysis vs Fundamental Analysis
Sell
14
Amplify Weight Loss Drug & Treatment ETF (THNR)
is a Sell
Is Amplify Weight Loss Drug & Treatment ETF a Buy or a Sell?
-
Amplify Weight Loss Drug & Treatment ETF stock is rated a SellThe current Amplify Weight Loss Drug & Treatment ETF [THNR] share price is $22.54. The Score for THNR is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
Amplify Weight Loss Drug & Treatment ETF Stock Info
Market Cap:
0
Price in USD:
22.54
Share Volume:
941
Amplify Weight Loss Drug & Treatment ETF 52-Week Range
52-Week High:
28.19
52-Week Low:
22.00
Sell
14
Amplify Weight Loss Drug & Treatment ETF (THNR)
is a Sell
Amplify Weight Loss Drug & Treatment ETF Share Price Forecast
-
What is the Amplify Weight Loss Drug & Treatment ETF stock price today?The Amplify Weight Loss Drug & Treatment ETF stock price is 22.54 USD today.
-
Will THNR stock go up or go down?Amplify Weight Loss Drug & Treatment ETF> share price is forecast to RISE/FALL based on technical indicators
-
Is Amplify Weight Loss Drug & Treatment ETF overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amplify Weight Loss Drug & Treatment ETF is overvalued.
Is Amplify Weight Loss Drug & Treatment ETF Stock a Buy?
-
Amplify Weight Loss Drug & Treatment ETF share price is 22.54 while THNR 8-day exponential moving average is 22.60, which is a Sell signal.
-
The stock price of THNR is 22.54 while Amplify Weight Loss Drug & Treatment ETF 20-day EMA is 22.78, which makes it a Sell.
-
Amplify Weight Loss Drug & Treatment ETF 50-day exponential moving average is 23.02 while THNR share price is 22.54, making it a Sell technically.
-
THNR stock price is 22.54 and Amplify Weight Loss Drug & Treatment ETF 200-day simple moving average is 7.42, creating a Buy signal.
Technical Analysis of Amplify Weight Loss Drug & Treatment ETF
Should I short Amplify Weight Loss Drug & Treatment ETF stock?
-
THNR Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting Amplify Weight Loss Drug & Treatment ETF is a Sell
-
Amplify Weight Loss Drug & Treatment ETF Relative Strength Index (RSI) is 44.25, which suggest Amplify Weight Loss Drug & Treatment ETF is oversold
-
The Bollinger Bands (25) for Amplify Weight Loss Drug & Treatment ETF is (22.5 - 23.38), which suggest Amplify Weight Loss Drug & Treatment ETF is a Sell
-
The Bollinger Bands (100) for Amplify Weight Loss Drug & Treatment ETF is (22.49 - 24.31), which suggest Amplify Weight Loss Drug & Treatment ETF is a Sell
* Amplify Weight Loss Drug & Treatment ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.